Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity

J Virol. 2005 Dec;79(24):15567-72. doi: 10.1128/JVI.79.24.15567-15572.2005.

Abstract

TRIM-CypA is an owl monkey-specific variant of the retrovirus restriction factor TRIM5alpha. Here, we exploit its modular domain organization and cyclosporine sensitivity to probe the kinetics and mechanism of TRIM5-mediated restriction. Time of addition/withdrawal experiments reveal that inhibition of incoming human immunodeficiency virus type 1 capsids by TRIM-CypA occurs within minutes of their delivery to the target cell cytoplasm. However, while TRIM-CypA restriction is partly dependent on a RING domain, restriction occurs independently of the ubiquitin/proteasome system. Moreover, tagged TRIM-CypA proteins can be fully active as restriction factors without forming cytoplasmic bodies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytoplasm / metabolism
  • HIV-1 / genetics
  • HIV-1 / metabolism*
  • Humans
  • Kinetics
  • Macaca mulatta
  • Proteasome Endopeptidase Complex / metabolism*
  • Proteins / genetics
  • Proteins / metabolism*
  • Ubiquitin / metabolism*
  • Ubiquitin-Protein Ligases

Substances

  • Proteins
  • Ubiquitin
  • TRIM5(alpha) protein, rhesus monkey
  • Ubiquitin-Protein Ligases
  • Proteasome Endopeptidase Complex